Osiden Injection

About Osiden 6 mg/2ml Injection

Osiden is a brand of Adenosine, an antiarrhythmic medicine given as an injection. It is used in hospital settings to treat a fast, irregular heartbeat known as paroxysmal supraventricular tachycardia.

What is Osiden 6 mg/2ml Injection?

Osiden 6 mg/2ml Injection is a sterile solution of Adenosine, an antiarrhythmic medicine given into a vein. It is used to restore a normal heart rhythm in people with paroxysmal supraventricular tachycardia (PSVT), including when the condition is linked to an accessory bypass tract such as Wolff-Parkinson-White syndrome. It works by slowing conduction through the A-V node and interrupting the reentry pathways that cause the fast rhythm. It is a hospital medicine given by a doctor or trained health professional as a rapid bolus injection. The doctor decides the dose and course for each patient.

Uses of Osiden

Osiden is used to convert paroxysmal supraventricular tachycardia (PSVT) back to normal sinus rhythm. This includes PSVT associated with accessory bypass tracts, such as Wolff-Parkinson-White syndrome. It is not a general treatment for all heart rhythm problems. Your doctor will confirm whether this medicine is suitable for your condition and will decide the dose and course.

How to use Osiden

Osiden is given by a doctor or trained health professional as a rapid bolus injection into a vein. It is not for self-administration at home. Because it acts very quickly, the injection is given in a setting where the heart rhythm can be monitored. The doctor decides the dose and course. Tell your doctor about all medicines you take before the injection is given.

Side effects of Osiden

Common effects include facial flushing, headache, sweating, palpitations, chest pain and low blood pressure. Some people feel short of breath or have chest pressure. Lightheadedness, dizziness, tingling or numbness in the arms, blurred vision, nausea and a metallic taste can also occur. More serious heart rhythm effects have been reported after marketing. Tell the doctor or nurse straight away if you feel unwell during or after the injection.

Safety and precautions

Osiden must not be used in people with second- or third-degree A-V block or sinus node disease unless they have a working artificial pacemaker. It must also be avoided by anyone with a known allergy to Adenosine. Caution is needed when other heart medicines are being used, because their effects on the heart's nodes can add up. The medicine is in US FDA pregnancy category C, so a pregnant woman should ask her doctor before receiving it. Always tell your doctor about your medical history and all medicines you take.

Frequently asked questions

What is Osiden and what kind of medicine is it?

Osiden is a brand of Adenosine, an antiarrhythmic medicine supplied as a 6 mg/2ml injection. It is given into a vein to treat paroxysmal supraventricular tachycardia (PSVT) and restore a normal heart rhythm.

Who should avoid Osiden or ask the doctor first?

People with second- or third-degree A-V block or sinus node disease should not receive it unless they have a working artificial pacemaker, and anyone allergic to Adenosine should avoid it. Tell your doctor about other heart medicines, pregnancy or any medical condition before the injection.

How should Osiden be stored?

Keep it in a cool, dry place protected from light and out of the reach of children. Do not refrigerate it, as crystals may form. If crystals appear, warm it to room temperature and make sure the solution is clear before use.

Who gives the Osiden injection and how is it given?

A doctor or trained health professional gives it as a rapid bolus injection into a vein, usually where the heart rhythm can be monitored. It is not for use at home. The doctor decides the dose and course for each patient.

Indications

Intravenous Adenosine is indicated for the following: Conversion to sinus rhythm of paroxysmal supraventricular tachycardia (PSVT), including that associated with accessory bypass tracts (Wolff-Parkinson-White Syndrome).

Pharmacology

This preparation is a sterile, nonpyrogenic solution for rapid bolus intravenous injection. Adenosine injection slows conduction time through the A-V node, can interrupt the reentry pathways through the A-V node, and can restore normal sinus rhythm in patients with paroxysmal supraventricular tachycardia.

Dosage & Administration

Adult:
  • Initial dose: 6 mg given as rapid IV bolus (administered over 1-2 second period).
  • Repeat administration: If the first dose does not result in elimination of the supraventricular tachycardia within 1-2 minutes, 12 mg should be given as rapid intravenous bolus. This 12 mg dose may be repeated for second time if required.
Pediatric: The dosages used in neonates, infants, children and adolescents were equivalent to those administered to adults on a weight basis.
  • Body weight < 50 kg: Initial dose - 0.05 to 0.1 mg/kg as a rapid IV bolus given either centrally or peripherally. A saline flush should follow.
  • Body weight > 50 kg: The adult dose is recommended. Doses greater than 12 mg are not recommended for adult and pediatric patients.

Repeat administration: If conversion of PSVT does not occur within 1-2 minutes, additional bolus injections of adenosine can be administered at incrementally higher doses, increasing the amount given by 0.05 to 0.1 mg/kg. A saline flush should follow. This process should continue until sinus rhythm is established or a maximum single dose of 0.3 mg/kg is used.

Interaction

Intravenous Adenosine injection has been effectively administered in the presence of other cardioactive drugs, such as Quinidine, beta- adrenergic blocking agents, Calcium channel blocking agents and angiotensin converting enzyme inhibitors without any change in the adverse reaction profile. Digoxin and Verapamil use may be rarely associated with ventricular fibrillation when combined with Adenosine. Because of the potential for additive or synergistic depressant effects on the SA and AV nodes, however, Adenosine should be used with caution in the presence of these agents. The use of Adenosine in patients receiving Digitalis may be rarely associated with ventricular fibrillation. The effects of Adenosine are antagonized by Methylxanthines, such as, Caffeine and Theophylline.

Contraindications

Intravenous Adenosine is contraindicated in:
  • Second- or third-degree A-V block (except in patients with a functioning artificial pacemaker).
  • Sinus node disease, such as sick sinus syndrome or symptomatic bradycardia (except in patients with a functioning artificial pacemaker).
  • Known hypersensitivity to Adenosine.

Side Effects

Cardiovascular: Facial flushing, headache, sweating, palpitations, chest pain, hypotension. Respiratory: Shortness of breath/dyspnea, chest pressure, hyperventilation, head pressure.

Central Nervous System: Lightheadedness, dizziness, tingling in arms, numbness, apprehension, blurred vision, burning sensation, heaviness in arms, neck and back pain.

Gastrointestinal: Nausea, metallic taste, tightness in throat, pressure in groin. In post-market clinical experience with Adenosine, cases of prolonged asystole, ventricular tachycardia, ventricular fibrillation, transient increase in blood pressure, bradycardia, hypotension, atrial fibrillation and bronchospasm, in association with Adenosine use, have been reported.

Pregnancy & Lactation

US FDA pregnancy category C. Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

Overdose Effects

The half-life of Adenosine is less than 10 seconds. Thus, adverse effects are generally rapidly self-limiting. Treatment of any prolonged adverse effects should be individualized and be directed toward the specific effect. Methylxanthines, such as, Caffeine and Theophylline, are competitive antagonists of Adenosine.

Storage Conditions

Store in cool dry place protected from light. Keep out of reach of children. Do not refrigerate as crystallization may occur. If crystallization has occurred, dissolve crystals by warming to room temperature. The solution must be clear at the time of use.

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.